Posts

Showing posts with the label Medical Marijuana

Medical Marijuana, Inc. Subsidiary Kannaway® Recognizes Second Brand Ambassador in Company History to Achieve International Director Title

Medical Marijuana, Inc. Subsidiary Kannaway® Announces July 25, 2017 Largest Revenue Day in Company History

Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Discusses Therapeutic Benefits of Cannabis During Annual International League Against Epilepsy Meeting

Medical Marijuana, Inc Major Investment AXIM Biotech Enters Agreement With Israel-Based CRO To Begin Clinical POC Study For Treatment Of Restless Leg Syndrome

Medical Marijuana, Inc. and Subsidiary HempMeds Brasil™ Garners Vast Media Coverage Across Brazil of Company and Cannabis Market Growth

Medical Marijuana, Inc. Subsidiary Kannaway® Announces Exclusive Red Carpet Event in Orange County, CA

Medical Marijuana, Inc. Announces Largest Revenue Quarter and Sales Month in Company History, 269% Revenue Increase From Q2 2016

Medical Marijuana, Inc. Major Investment AXIM Biotech Files Patent On Controlled Release Chewing Gum To Provide Opioid Addiction Treatment